Guanze Medical Information Industry (Holding) Co., Ltd. filed its monthly return for the period ended 31 March 2026, reporting no changes to either authorised or issued share capital.

• Authorised share capital remained at 10.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 100.00 million.

• Issued share capital stayed flat at 950 million ordinary shares; the company held no treasury shares.

• The company confirmed that it continued to meet the Main Board’s minimum public-float requirement of 25 percent of issued shares.

• No share options, warrants, convertibles, or other equity-linked instruments were granted, exercised, converted, or cancelled during the month.

• The return was submitted to Hong Kong Exchanges and Clearing Limited on 8 April 2026.

The absence of equity movements in March signals a stable capital structure for Guanze Medical as it progresses through FY26.